# Mo. Attorney General sends prescription manufacturer Eli Lilly cease-and-desist over drug price policy

> **Open Intelligence Dossier** · First detected: 2026-10-27 21:40 UTC · Category: Business

## Executive Summary
Missouri's Attorney General issues a cease-and-desist letter to drug manufacturer Eli Lilly over a contested pricing policy.

## Intelligence Brief
According to these sources, the Missouri Attorney General has formally issued a cease-and-desist letter to Eli Lilly. The action targets the pharmaceutical company&amp;#039;s requirement that hospitals submit specific data when seeking 340B drug discounts, a practice that has triggered an intense pricing dispute involving institutions such as MU Health Care. Simultaneously, reporting highlights broader legal challenges against the manufacturer.


The Boston Globe covers a lawsuit filed by MGH, Brigham, and other hospitals explicitly alleging extortion in connection with the drug discount program. Law360 frames these developments within a larger pattern of ongoing legal battles, identifying three critical cases to watch as the 340B program disputes continue to unfold across multiple jurisdictions and involve various healthcare providers alongside state officials. The context provided by the coverage roots these developments in the operational tensions surrounding the 340B drug pricing program, which requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations at significantly reduced prices.


The conflict escalated as Eli Lilly implemented data-sharing requirements that participating hospitals and state authorities are now aggressively challenging through both regulatory warnings and federal litigation, asserting that the manufacturer&amp;#039;s conditions improperly restrict access to mandated discounts. As the situation develops, current coverage does not yet specify the full scope of Eli Lilly&amp;#039;s formal response to the Missouri Attorney General&amp;#039;s cease-and-desist letter or the immediate operational changes the company might implement. Observers and legal analysts are advised to monitor the progression of the hospital lawsuits detailed by The Boston Globe and the broader 340B litigation tracked by Law360 to see how courts evaluate the legality of the disputed data requirements and pricing policies.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Law360 | 3 Cases To Watch In The 340B Battles | [Source Link](https://news.google.com/rss/articles/CBMiggFBVV95cUxQb0hka1hBSVpJOFduaDNYTWlTLTlmYWE4YUJRWXoyQm1wdjhGZmhVd2lSVTh3dEg5cGlSUU5JQ3JFU2ZZWUxaSmxBVEppQi1iZnBrZDVuQll0eEc5ZkJ0blEtZy1BTWN5NUxMQlc3bDZpZndVenJHdFdLdDJtcmFvbUVR0gFyQVVfeXFMUDZzVDlEX0lKQWYtUlRIYmRCNUplMEExN2t0alZCbHVNOWZGdHJaLTI5Sk9FSFFRMHROY3pOejhrX19RMGtWUF9kd3g0MmIwVFBpME1GUFBVWEZDcExjQnd0NUNfb21BSjJPLTVUdERtRmNB?oc=5) |
| STAT | Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxNYm1hYUdkSUY1elVxam9DME4tTjRKMDlnb3U5Qmc5R3FhaWpaaEhtRzZsTzNPTlVIMVRjZ2NXV1hOTEhjZTJ4MDkwZDRKaEh6YTFzbGZyYktSUHhaaUtUb1puUExKaFl5RnJrQ3FuX292YnJoUTVCWEhZZ2VHcnVnTzJQNUNYV3NzXzA1R0hYcHZmMWlnX1JJUw?oc=5) |
| The Boston Globe | MGH, Brigham, other hospitals sue Eli Lilly alleging ‘extortion’ in drug discount program | [Source Link](https://news.google.com/rss/articles/CBMihgFBVV95cUxQaUNWTldoU21Yc0sweVZOOVdSeXhyZHNTajNmcFhlX0IxTHpHa1JMNGJWdV9ZZzlGUlNxR0FkQ0hSdGhzbTFNUlRSQ3pjdzRFZDJaaVlyRTV6MlpyLXdISDRBSkF0bW1PTDhMQ0xDakIyVDJKY0t6akhiSU5uWWYzZkE2TXV1Zw?oc=5) |
| ABC17NEWS | AG sends cease-and-desist letter to pharmaceutical company after pricing spat with MU Health Care | [Source Link](https://news.google.com/rss/articles/CBMi_gFBVV95cUxOWUNXcXdLVllwSmlQXzUxajVqNnI2TGh0LS1VV29ZM3N1cmF6MmpoNEI1VUpjcTJQcFhNQ2JxUmFoSmVjSFBaUjNTb3pMNk1yd2IyT0RTS1pTaFFQaUpfT3VzSThMaEZ3RmVFZjdTMC1rOXhHTnJ1VGdjNUJabG1vbXFiWDZrTEVnRnhGcVVESjZYYmVLTEJmem9ILTVqSkpaNS1wbG1qdFJEX29iUkFxSWVhSjRaclRYcGtzX3JreDJ6Zk9JTFFvbFRrODJ6LXduZzd2TEdId1RyQ1AyZmpIQjJqNVU2M2h1LWlWaC10QVJiU3ZfSnp6Tm5JT3BNUQ?oc=5) |
| KOMU 8 | Missouri Attorney General sends cease-and-desist letter to drug manufacturer | [Source Link](https://news.google.com/rss/articles/CBMi7wFBVV95cUxNdjlnWUxIUS05TFJYTm10OUJsSzdwVVQ5a2h0dUc1RU5zVXEwYVpMY1IxcU9PY2lELUI3dlNCQ0Q4dGJBT2tveDJVMTc2dnlhdWU4a1VCUW5hRkE2TDJxR3RUdjliT1hYVEdUUkxRX1dFQzBiRVl2MEtZNGpaQVpqU1k3VmltdkFYRlg2SnVBZVo0bzRDbkpvVmRFOVV6WkhULVlMcXpYQ1hqdWd2SEtOSXVDVDdYeHNZMlNWclh4WEZTMWY5MHFWV0g1UEdycTRmREVWZm11dGlsNWNrcmF0UW5MdjVmM3pLbGoybndpdw?oc=5) |
| KMOV | Mo. Attorney General sends prescription manufacturer Eli Lilly cease-and-desist over drug price policy | [Source Link](https://news.google.com/rss/articles/CBMi2AFBVV95cUxONnNzMnVoU1F3ZkZ6ZEI3eGN4U2FXUVZFS0RDRjdpMmlrWEZiUWhJUWtEbXA4aDFLU0tBUWNZdkpiMXY3eTBXY2JrQ2RveExKdFJ5Wi1HYURpZEN2MkswS3JKb1l6QlRMbGFIOXlHU0pLQk1xTEpkZ0swVmE2MUF5cVA1dE5TYUU3REh2UmdzaU5MZ3d1alBhc3YtdnpMcEYtTDdjMmJfYjR2aUVRNFloWGI4QjVlSEd1N3RhNWh2NktJam1ObEpaLXFubG9VcDhyV3VEdU0tQXg?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-27/mo-attorney-general-sends-prescription-manufacturer-eli-lilly-cease-and-desist*
